The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Lab-on-a-chip and Microarrays (BIOCHIP)-Global Market Insights and Sales Trends 2025

Lab-on-a-chip and Microarrays (BIOCHIP)-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1867371

No of Pages : 104

Synopsis
Biochips are collections of tiny test sites (microarrays) arranged on a solid substrate, allowing many tests to be performed simultaneously for higher throughput and speed. Normally, the surface area of a biochip is no larger than a fingernail. Just as computer chips can perform millions of mathematical operations in a second, biochips can perform thousands of biological reactions, such as decoding genes, in a matter of seconds.
The global Lab-on-a-chip and Microarrays (BIOCHIP) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Lab-on-a-chip and Microarrays (BIOCHIP) in various end use industries. The expanding demands from the Genomics, Proteomics, Cell Assays and Clinical Diagnostics, are propelling Lab-on-a-chip and Microarrays (BIOCHIP) market. DNA Microarrays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Microfluidics segment is estimated at % CAGR for the next seven-year period.
Following a strong growth of 26.2 percent in the year 2021, WSTS revised it down to a single digit growth for the worldwide semiconductor market in 2022 with a total size of US$580 billion, up 4.4 percent. WSTS lowered growth estimation as inflation rises and end markets seeing weaker demand, especially those exposed to consumer spending. While some major categories are still double-digit year-over-year growth in 2022, led by Analog with 20.8 percent, Sensors with 16.3 percent, and Logic with 14.5 percent growth. Memory declined with 12.6 percent year over year. In 2022, all geographical regions showed double-digit growth except Asia Pacific. The largest region, Asia Pacific, declined 2.0 percent. Sales in the Americas were US$142.1 billion, up 17.0% year-on-year, sales in Europe were US$53.8 billion, up 12.6% year-on-year, and sales in Japan were US$48.1 billion, up 10.0% year-on-year. However, sales in the largest Asia-Pacific region were US$336.2 billion, down 2.0% year-on-year.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lab-on-a-chip and Microarrays (BIOCHIP), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lab-on-a-chip and Microarrays (BIOCHIP) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lab-on-a-chip and Microarrays (BIOCHIP) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lab-on-a-chip and Microarrays (BIOCHIP) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lab-on-a-chip and Microarrays (BIOCHIP) covered in this report include Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Beckman Coulter, Cepheid, Fluidigm, GE Healthcare, Roche Holding and Illumina, etc.
The global Lab-on-a-chip and Microarrays (BIOCHIP) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Agilent Technologies
Bio-Rad Laboratories
Beckman Coulter
Cepheid
Fluidigm
GE Healthcare
Roche Holding
Illumina
Biomerieux
Thermo Fisher Scientific
PerkinElmer
Global Lab-on-a-chip and Microarrays (BIOCHIP) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lab-on-a-chip and Microarrays (BIOCHIP) market, Segment by Type:
DNA Microarrays
Microfluidics
Global Lab-on-a-chip and Microarrays (BIOCHIP) market, by Application
Genomics
Proteomics
Cell Assays
Clinical Diagnostics
Drug Discovery
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Lab-on-a-chip and Microarrays (BIOCHIP) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Lab-on-a-chip and Microarrays (BIOCHIP)
1.1 Lab-on-a-chip and Microarrays (BIOCHIP) Market Overview
1.1.1 Lab-on-a-chip and Microarrays (BIOCHIP) Product Scope
1.1.2 Lab-on-a-chip and Microarrays (BIOCHIP) Market Status and Outlook
1.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Lab-on-a-chip and Microarrays (BIOCHIP) Market Size by Region (2018-2029)
1.4 Global Lab-on-a-chip and Microarrays (BIOCHIP) Historic Market Size by Region (2018-2023)
1.5 Global Lab-on-a-chip and Microarrays (BIOCHIP) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Lab-on-a-chip and Microarrays (BIOCHIP) Market Size (2018-2029)
1.6.1 North America Lab-on-a-chip and Microarrays (BIOCHIP) Market Size (2018-2029)
1.6.2 Europe Lab-on-a-chip and Microarrays (BIOCHIP) Market Size (2018-2029)
1.6.3 Asia-Pacific Lab-on-a-chip and Microarrays (BIOCHIP) Market Size (2018-2029)
1.6.4 Latin America Lab-on-a-chip and Microarrays (BIOCHIP) Market Size (2018-2029)
1.6.5 Middle East & Africa Lab-on-a-chip and Microarrays (BIOCHIP) Market Size (2018-2029)
2 Lab-on-a-chip and Microarrays (BIOCHIP) Market by Type
2.1 Introduction
2.1.1 DNA Microarrays
2.1.2 Microfluidics
2.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Lab-on-a-chip and Microarrays (BIOCHIP) Historic Market Size by Type (2018-2023)
2.2.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Lab-on-a-chip and Microarrays (BIOCHIP) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Lab-on-a-chip and Microarrays (BIOCHIP) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Lab-on-a-chip and Microarrays (BIOCHIP) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Lab-on-a-chip and Microarrays (BIOCHIP) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Lab-on-a-chip and Microarrays (BIOCHIP) Revenue Breakdown by Type (2018-2029)
3 Lab-on-a-chip and Microarrays (BIOCHIP) Market Overview by Application
3.1 Introduction
3.1.1 Genomics
3.1.2 Proteomics
3.1.3 Cell Assays
3.1.4 Clinical Diagnostics
3.1.5 Drug Discovery
3.1.6 Others
3.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Lab-on-a-chip and Microarrays (BIOCHIP) Historic Market Size by Application (2018-2023)
3.2.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Lab-on-a-chip and Microarrays (BIOCHIP) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Lab-on-a-chip and Microarrays (BIOCHIP) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Lab-on-a-chip and Microarrays (BIOCHIP) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Lab-on-a-chip and Microarrays (BIOCHIP) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Lab-on-a-chip and Microarrays (BIOCHIP) Revenue Breakdown by Application (2018-2029)
4 Lab-on-a-chip and Microarrays (BIOCHIP) Competition Analysis by Players
4.1 Global Lab-on-a-chip and Microarrays (BIOCHIP) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lab-on-a-chip and Microarrays (BIOCHIP) as of 2022)
4.3 Date of Key Players Enter into Lab-on-a-chip and Microarrays (BIOCHIP) Market
4.4 Global Top Players Lab-on-a-chip and Microarrays (BIOCHIP) Headquarters and Area Served
4.5 Key Players Lab-on-a-chip and Microarrays (BIOCHIP) Product Solution and Service
4.6 Competitive Status
4.6.1 Lab-on-a-chip and Microarrays (BIOCHIP) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Lab-on-a-chip and Microarrays (BIOCHIP) Products, Services and Solutions
5.1.4 Abbott Laboratories Lab-on-a-chip and Microarrays (BIOCHIP) Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Agilent Technologies
5.2.1 Agilent Technologies Profile
5.2.2 Agilent Technologies Main Business
5.2.3 Agilent Technologies Lab-on-a-chip and Microarrays (BIOCHIP) Products, Services and Solutions
5.2.4 Agilent Technologies Lab-on-a-chip and Microarrays (BIOCHIP) Revenue (US$ Million) & (2018-2023)
5.2.5 Agilent Technologies Recent Developments
5.3 Bio-Rad Laboratories
5.3.1 Bio-Rad Laboratories Profile
5.3.2 Bio-Rad Laboratories Main Business
5.3.3 Bio-Rad Laboratories Lab-on-a-chip and Microarrays (BIOCHIP) Products, Services and Solutions
5.3.4 Bio-Rad Laboratories Lab-on-a-chip and Microarrays (BIOCHIP) Revenue (US$ Million) & (2018-2023)
5.3.5 Beckman Coulter Recent Developments
5.4 Beckman Coulter
5.4.1 Beckman Coulter Profile
5.4.2 Beckman Coulter Main Business
5.4.3 Beckman Coulter Lab-on-a-chip and Microarrays (BIOCHIP) Products, Services and Solutions
5.4.4 Beckman Coulter Lab-on-a-chip and Microarrays (BIOCHIP) Revenue (US$ Million) & (2018-2023)
5.4.5 Beckman Coulter Recent Developments
5.5 Cepheid
5.5.1 Cepheid Profile
5.5.2 Cepheid Main Business
5.5.3 Cepheid Lab-on-a-chip and Microarrays (BIOCHIP) Products, Services and Solutions
5.5.4 Cepheid Lab-on-a-chip and Microarrays (BIOCHIP) Revenue (US$ Million) & (2018-2023)
5.5.5 Cepheid Recent Developments
5.6 Fluidigm
5.6.1 Fluidigm Profile
5.6.2 Fluidigm Main Business
5.6.3 Fluidigm Lab-on-a-chip and Microarrays (BIOCHIP) Products, Services and Solutions
5.6.4 Fluidigm Lab-on-a-chip and Microarrays (BIOCHIP) Revenue (US$ Million) & (2018-2023)
5.6.5 Fluidigm Recent Developments
5.7 GE Healthcare
5.7.1 GE Healthcare Profile
5.7.2 GE Healthcare Main Business
5.7.3 GE Healthcare Lab-on-a-chip and Microarrays (BIOCHIP) Products, Services and Solutions
5.7.4 GE Healthcare Lab-on-a-chip and Microarrays (BIOCHIP) Revenue (US$ Million) & (2018-2023)
5.7.5 GE Healthcare Recent Developments
5.8 Roche Holding
5.8.1 Roche Holding Profile
5.8.2 Roche Holding Main Business
5.8.3 Roche Holding Lab-on-a-chip and Microarrays (BIOCHIP) Products, Services and Solutions
5.8.4 Roche Holding Lab-on-a-chip and Microarrays (BIOCHIP) Revenue (US$ Million) & (2018-2023)
5.8.5 Roche Holding Recent Developments
5.9 Illumina
5.9.1 Illumina Profile
5.9.2 Illumina Main Business
5.9.3 Illumina Lab-on-a-chip and Microarrays (BIOCHIP) Products, Services and Solutions
5.9.4 Illumina Lab-on-a-chip and Microarrays (BIOCHIP) Revenue (US$ Million) & (2018-2023)
5.9.5 Illumina Recent Developments
5.10 Biomerieux
5.10.1 Biomerieux Profile
5.10.2 Biomerieux Main Business
5.10.3 Biomerieux Lab-on-a-chip and Microarrays (BIOCHIP) Products, Services and Solutions
5.10.4 Biomerieux Lab-on-a-chip and Microarrays (BIOCHIP) Revenue (US$ Million) & (2018-2023)
5.10.5 Biomerieux Recent Developments
5.11 Thermo Fisher Scientific
5.11.1 Thermo Fisher Scientific Profile
5.11.2 Thermo Fisher Scientific Main Business
5.11.3 Thermo Fisher Scientific Lab-on-a-chip and Microarrays (BIOCHIP) Products, Services and Solutions
5.11.4 Thermo Fisher Scientific Lab-on-a-chip and Microarrays (BIOCHIP) Revenue (US$ Million) & (2018-2023)
5.11.5 Thermo Fisher Scientific Recent Developments
5.12 PerkinElmer
5.12.1 PerkinElmer Profile
5.12.2 PerkinElmer Main Business
5.12.3 PerkinElmer Lab-on-a-chip and Microarrays (BIOCHIP) Products, Services and Solutions
5.12.4 PerkinElmer Lab-on-a-chip and Microarrays (BIOCHIP) Revenue (US$ Million) & (2018-2023)
5.12.5 PerkinElmer Recent Developments
6 North America
6.1 North America Lab-on-a-chip and Microarrays (BIOCHIP) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Lab-on-a-chip and Microarrays (BIOCHIP) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Lab-on-a-chip and Microarrays (BIOCHIP) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Lab-on-a-chip and Microarrays (BIOCHIP) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Lab-on-a-chip and Microarrays (BIOCHIP) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Lab-on-a-chip and Microarrays (BIOCHIP) Market Dynamics
11.1 Lab-on-a-chip and Microarrays (BIOCHIP) Industry Trends
11.2 Lab-on-a-chip and Microarrays (BIOCHIP) Market Drivers
11.3 Lab-on-a-chip and Microarrays (BIOCHIP) Market Challenges
11.4 Lab-on-a-chip and Microarrays (BIOCHIP) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’